Home > Press > GenScript Launches Online Quotation System for Polyclonal Antibody Service
Abstract:
Polyclonal antibody services now are equipped with online quotation system for the first time.
Internationally recognized biology contract research organization GenScript USA Inc. has developed and launched an online quotation system for its polyclonal antibody services to enhance customers' user experiences online and serves as a value added feature.
The newly launched online quotation system for polyclonal antibody services is the first in the industry. The system allows customers to easily communicate with GenScript regarding their specific needs for the polyclonal antibody services. On one hand the system provides customer with fast quotation results, on the other it is designed to provide alternative solutions to both standardize the communication with clients and avoid mistakes.
"GenScript's online quotation system for polyclonal antibody services is the distillation of our years of past experience with polyclonal antibody projects." commented David Chang, director of GenScript's Antibody Department, "Almost all possible scenarios are outlined, which is very likely to increase the chances for us to deliver satisfactory results."
GenScript has an AAALAC accredited animal facility and is able to produce polyclonal antibodies in rabbit, mouse, rat, chicken, goat, and many other species. With the help of proprietary technologies including OptimumAntigenTM design tool, T-MaxTM adjuvant, and nanotechnology, GenScript is able to deliver polyclonal antibodies with guaranteed high quality.
####
About GenScript
GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. The renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development.
Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.
For more information, please click here
Contacts:
Sally Wang
Executive Vice President
GENSCRIPT USA Inc.
1-(732) 885-9188
Copyright © GenScript
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Products
Spectradyne Partners with Particle Technology Labs for Measurement Services December 6th, 2018
Mode-Changing MEMS Accelerometer from STMicroelectronics Combines High Measurement Resolution and Ultra-Low Power for Industrial Applications November 7th, 2018
Fat-Repellent Nanolayers Can Make Oven Cleaning Easier October 17th, 2018
Aculon, Inc. Enters into Strategic Partnership Agreement with Henkel Corporation to Supply Key Mobile Device Manufacturers with NanoProof® PCB Waterproof Technology October 17th, 2018
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||